重大事项：
和黄医药(00013)宣布武田获得FRUZAQLA® (呋喹替尼/fruquintinib) 在日本的上市批准
兖矿能源(01171)境外控股子公司沙尔夫公司股票转换上市板块
齐鲁高速(01576)：济菏高速济南长清段(殷家林枢纽立交至孝里互通段)将于9月26日提前恢复双向通行
上海医药(02607)子公司信谊金朱成为氨磺必利口服溶液上市许可持有人
世茂服务(00873)附属拟2.5亿元出售无锡市金沙田科技60%股权
白云山(00874)分公司化学制药厂《药品生产许可证》变更
兴达国际(01899)获Great Trade Limited提全面现金要约 9月25日复牌
君实生物(01877)：特瑞普利单抗获得欧盟委员会批准上市
康哲药业(00867)：磷酸芦可替尼乳膏(白癜风适应症)中国上市许可申请获受理
中国能源建设(03996)附属中标珠海市金湾游艇产业园游艇研发及制造项目填海工程勘察设计施工总承包项目
经营业绩：
湾区发展(00737)：广深高速公路8月路费收入2.57亿元，同比减少4%
大象未来集团(02309)发布年度业绩，股东应占亏损1.83亿港元 同比扩大612.39%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.